Skip to main content
Smart Investors Daily
PM

AMEX · PMI

Picard Medical, Inc.

Healthcare · Medical - Devices

$12.75

Up+$2.70 (+21.18%)

Updated Oct 19, 2026, 8:31 PM

SID Score

4.7/10

Composite research score

Smart Money

58/100

Neutral

Market cap
3.85B
P/E ratio
-4.16
Dividend yield
0.00%
52-week range
$2.65 – $684.00
Volume
1.61M
Avg. volume
2.55M

Price performance · PMI

PMI price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 16, 2026

PMI closed at $12.75 after 20 trading sessions, up 202.85% for the selected period.

Last close
$12.75
Period change
+202.85%
Period low
$4.20
Period high
$15.33
Daily close
View OHLC price history
PMI OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 16, 2026$12.21$13.1584$8.38$12.751.61M
Oct 15, 2026$13.67$18.23$10.00$10.001.49M
Oct 14, 2026$13.61$14.50$12.68$12.68160.87K
Oct 13, 2026$11.22$17.50$10.5903$15.331.18M
Oct 12, 2026$9.15$12.69$9.0125$11.34693.87K
Oct 9, 2026$9.51$9.72$8.15$9.48300.94K
Oct 8, 2026$9.29$10.10$8.85$9.68259.12K
Oct 7, 2026$8.70$10.1933$7.63$9.37792.51K
Oct 6, 2026$6.80$9.00$6.69$8.74912.71K
Oct 5, 2026$6.15$7.20$5.56$6.93899.52K
Oct 2, 2026$4.32$5.90$3.8501$5.78892.57K
Oct 1, 2026$4.16$4.355$4.15$4.3216.16K
Sep 30, 2026$4.42$4.4855$4.15$4.2023.64K
Sep 29, 2026$4.67$4.7494$4.42$4.4521.9K
Sep 28, 2026$4.49$4.7498$4.0301$4.6152.04K
Sep 25, 2026$4.72$4.80$4.56$4.6234.37K
Sep 24, 2026$4.50$4.87$4.28$4.8756.98K
Sep 23, 2026$4.25$4.58$4.25$4.5592.47K
Sep 22, 2026$3.89$4.33$3.83$4.33216.27K
Sep 21, 2026$4.36$4.639$4.20$4.21173.62K

Latest PMI news

The latest Smart Investors Daily articles mentioning PMI.

PMI research

Overview

Company profile and research snapshot.

Company profile

Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
PMI recent ratings
DateFirmRatingTarget
Jun 3, 2026HC Wainwright & Co.Neutral—
May 18, 2026HC Wainwright & Co.Neutral—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Oct 16, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares increased by 27.9% to $2.79 during Friday's pre-market session. The company's market cap stands at $5.2 million. Picard Medical (AMEX:PMI) stock moved upwards

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.